April/Avril 2015

We are proud to announce that our first cell models developed internally during these last months were presented during the ELRIGfr conference at the forum Labo in Paris. The first poster presented some of our results about the genotoxicity and steatosis assays on HepG2 cells. The second poster showed results of our Parkinson model with co-cultured neuronal cells and macrophages, as well as our first 3D culture results obtained by using the CELENYS innovative technology, Biomimesys®. This poster won the innovation award. Please go to our updated services pages or contact us for more information.

Nous sommes fiers de vous annoncer que nos premiers modèles cellulaires développés au sein d’HCS Pharma ces derniers mois ont été présentés sous la forme de deux posters au sein du congrès ELRIGfr au forum labo. Le premier poster présentait une partie de nos résultats sur les tests de génotoxicité et de stéatose sur cellules HepG2. Le second poster montrait nos résultats d’un modèle de Parkinson en co-culture sur cellules neuronales et macrophagiques ainsi que nos premiers résultats de culture 3D sur une technologie innovante de CELENYS, le Biomimesys®. Celui-ci a fait l’objet du prix du poster de l’innovation. N’hésitez pas à aller sur nos pages services qui ont été mises à jour ou à nous contacter pour plus d’information.

Updated services pages !

You will find here a new presentation of our services in Toxicology Area (Genotoxicity assay, Cell cycle arrest, Cytotoxicity assay : Hepatotoxicity  and Neurotoxicity assay, Hepatotoxicity : Steatosis) and Neurosciences (Parkinson assay)

HCS Pharma presented two posters at ELRIGfr during forum labo 2015

Nathalie and Julian was present during ELRIGfr event last week. They presented their company, their work and their collaborations. They have also presented two posters, one on co-culture model of Parkinson and first results in 3D dimension, and the other one, on genotoxicity and steatosis assay on HepG2 cells.

CELENYS won the first french innovation trophee at Forum labo 2015

We are proud to work with CELENYS to implement new assays in 3D culture since We think that they have a really innovative 3D culture plate that mimics very well the cellular environment. And for their innovative plates, our partner CELENYS has been awarded at Forum Labo 2015 with the innovation price for their culture plate, Biomimesys®. Congratulations to CELENYS for their price.
 

Award of innovative poster for HCS Pharma during ELRIGfr event

We are really pleased to announce that we have received the award of innovative poster for our Parkinson model and first results in 3D culture. This award recognizes our collaboration with two other startups to implement new innovative assays. These two other partnairs are CELENYS, which develops new plate for 3D culture which mimics the extracellular matrix, and QuantaCell, which develops new IT tools for image and results/statistics analysis (eg for 3D analysis and/or timelapse).

HCS Pharma meets the Dell "Center for Entrepreneurs" program

Last week, we were very pleased to meet the french team for Dell worldwide program "Center for Entrepreneurs". After useful discussions about data management, data storage, visualisation and data maining, we improved our picture's workflows and we imagined many new and innovative ways to develop ! The « Speed Mentoring » with Dell's experts was very effective.

Services

Explain us your requirements and we develop your assays to best meet your needs !

Our vision

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

View this email in your browser
Website
Website
LinkedIn
LinkedIn
Twitter
Twitter
Google Plus
Google Plus
Contact Us
Contact Us
Copyright © 2015 HCS Pharma, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp